Search results for "Demyelinating disease"

showing 5 items of 35 documents

Neuronavigation-guided biopsy for differential diagnosis of pseudotumoral demyelinating brain lesions

2014

Abstract Marburg's disease (MD) is an extremely rare and aggressive form of multiple sclerosis (MS). In some cases, MD presents with tumefactive demyelinating lesions with a “tumor-like” appearance in MRI images, for which it may be difficult to achieve a form of differential diagnosis between definitive tumors or abscesses. Here we report a case of MD histopathologically confirmed after neuronavigationguided biopsy. Postoperative course was uneventful and following discharge, the patient attended outpatient follow-up appointments and received i.v. cyclophopsphamide, achieving progressive clinical remission. A nine-month follow-up brain MRI scan with gadolinium showed no signs of progressin…

Neuronavigation-guided biopsymedicine.medical_specialtyStereotactic biopsyNeuronavigationlcsh:SurgeryBrain damageDiseaselcsh:RC346-429BiopsyPseudotumoral lesionsmedicineDemyelinating diseaseMarburg's disease (MD); Pseudotumoral lesions; Neuronavigation-guided biopsylcsh:Neurology. Diseases of the nervous systemmedicine.diagnostic_testbusiness.industrySettore MED/27 - NeurochirurgiaMultiple sclerosislcsh:RD1-811medicine.diseaseSurgeryPseudotumoral lesionMarburg's disease (MD)SurgerySettore MED/26 - NeurologiaNeurology (clinical)Differential diagnosismedicine.symptombusinessInterdisciplinary Neurosurgery
researchProduct

Identification of inflammatory neuronal injury and prevention of neuronal damage in multiple sclerosis: hope for novel therapies?

2013

Importance Although multiple sclerosis (MS) has long been considered the prototype for an inflammatory, demyelinating disease of the central nervous system, modern histopathology and imaging techniques show that significant damage to neuronal structures already start occurring in the earliest stages of the disease. As the disease progresses, the extent of neuronal pathology accumulates. Therapeutic progress in terms of the prevention of increased disability has only just begun. Objective To review possible diagnostic improvements of neuronal compartment pathology as well as direct therapeutic interventions based on reports from the last decade and outline clinical results from studies and p…

NeuronsMultiple Sclerosisbusiness.industryMultiple sclerosisCentral nervous systemAnti-Inflammatory AgentsDiseasemedicine.diseaseNeuroprotectionClinical trialmedicine.anatomical_structureNeuronal damageNerve DegenerationDemyelinating diseasemedicineDisease ProgressionHumansIdentification (biology)Neurology (clinical)businessNeuroscienceJAMA neurology
researchProduct

Prognostic indicators in pediatric clinically isolated syndrome

2017

To assess prognostic factors for a second clinical attack and a first disability worsening event in pediatric clinically isolated syndrome (pCIS) suggestive of Multiple Sclerosis (MS) patients. Objective: To assess prognostic factors for a second clinical attack and a first disability-worsening event in pediatric clinically isolated syndrome (pCIS) suggestive of multiple sclerosis (MS) patients. Methods: A cohort of 770 pCIS patients was followed up for at least 10 years. Cox proportional hazard models and Recursive Partitioning and Amalgamation (RECPAM) tree-regression were used to analyze data. Results: In pCIS, female sex and a multifocal onset were risk factors for a second clinical att…

RegistrieMaleMultiple SclerosisAdolescentAdolescent; Age of Onset; Child; Demyelinating Diseases; Female; Follow-Up Studies; Humans; Male; Multiple Sclerosis; Prognosis; Retrospective Studies; Risk Factors; Disease Progression; Registries; Neurology; Neurology (clinical)PrognosiONSET MULTIPLE-SCLEROSISCHILDHOODCHILDRENPARACLINICAL FEATURESDISABILITY PROGRESSIONNOFollow-Up StudieRisk FactorsRetrospective Studieprognostic indicatorsMultiple Sclerosipediatric multiple sclerosis prognosis indicatorsHumansRegistriesAge of OnsetChildOPTIC NEURITISRetrospective StudiesRisk FactorDemyelinating DiseaseNATURAL-HISTORYPrognosismultiple sclerosis clinically isolated syndrome prognostic indicatorsNeurologyTRANSVERSE MYELITISclinically isolated syndromeINTERFERON BETA-1BDisease ProgressionSettore MED/26 - NeurologiaFemaleNeurology (clinical)FOLLOW-UPDemyelinating DiseasesFollow-Up StudiesHuman
researchProduct

The actual state of computerized tomography (CT)-computer assisted tomography (CAT).

1977

medicine.medical_specialtyBrain Diseasesbusiness.industryBrain NeoplasmsComputer assisted tomographyBrainDiagnosis DifferentialCerebrovascular DisordersNeurologySpinal CordBrain InjuriesmedicineHumansMedical physicsSpinal DiseasesNeurology (clinical)RadiologyTomographyState (computer science)businessPneumoencephalographyTomography X-Ray ComputedNeuroradiologyDemyelinating DiseasesHydrocephalusJournal of neurology
researchProduct

Answer to: The possible risk of cancer in multiple sclerosis patients: a controversial issue

2010

medicine.medical_specialtyMultiple Sclerosis | Demyelinating Diseases | concentric sclerosisNeurologybusiness.industryMultiple sclerosisPhysical therapyMedicineCancerSettore MED/26 - NeurologiaNeurology (clinical)businessIntensive care medicinemedicine.diseaseEuropean Journal of Neurology
researchProduct